Pipeline watch: Which ESMO presentations matter most

Wednesday, October 22, 2025  |  10:30 AM – 12:30 PM ET

The cancer drug development world is gearing up for ESMO 2025, where a wave of clinical readouts could shift competitive dynamics across the industry.

As companies prepare to present their latest data, critical questions loom: Which novel targets will deliver on their promise, and what unexpected results might force strategy pivots?

With pipeline investments under closer scrutiny than ever, identifying the readouts that truly matter is essential for executives. Join our expert discussion after the conference as we decode the competitive implications.

Sponsorship opportunities available.
Contact Meg at mestacio@endpointsnews.com to learn how you can support Endpoints at ESMO '25.